trending Market Intelligence /marketintelligence/en/news-insights/trending/7NUt5a-L2BkLYJ4LD-_vxw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

EQT to sell Clinical Innovations to Laborie Medical for $525M

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

EQT to sell Clinical Innovations to Laborie Medical for $525M

Asset management firms EQT Mid Market US and EQT Mid Market Asia III agreed to sell Salt Lake City, Utah-based healthcare equipment company Clinical Innovations LLC to Laborie Medical Technologies Inc. for $525 million.

The deal is expected to close in early 2020, subject to customary approvals.

Clinical Innovations provides medical devices for labor and delivery and neonatal intensive care.

Mississauga, Ontario-based Laborie Medical is a private company that develops and markets medical devices used in the urology, gynecology and colorectal fields for diagnostic and treatment purposes.

Moelis & Co. LLC is serving as financial adviser and Simpson Thacher & Bartlett LLP is acting as a legal adviser to EQT and Clinical Innovations.